IrtemazoleAlternative Names: R 60844
Latest Information Update: 17 Feb 1995
$50 / €47 *
At a glance
- Originator Janssen L.P.
- Class Benzimidazoles; Small molecules; Uricosurics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gout
Most Recent Events
- 17 Feb 1995 Discontinued-I for Gout in Germany (Unknown route)
- 17 Feb 1995 Discontinued-II for Gout in Belgium (Unknown route)